SCHEMBL26058249

SCHEMBL26058249

CC(C)(C)OC(=O)N1CCC2(CC1)OCCc1sc(Br)cc12

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 3/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
ESR2 Q92731 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
NR1H2 P55055 1/20 0.36
MKNK1 Q9BUB5 3/20 0.36
ALK Q9UM73 1/20 0.36
SCD5 Q86SK9 1/20 0.36
NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25359917 0.87 AVPR1A (0.41) AVPR1AUSP2SMN1; SMN2HDAC1HDAC8
SCHEMBL26058252 0.84 ACACB (0.34) AVPR1AGPR119NR1H2MKNK1
SCHEMBL31387347 0.84 ACACB (0.34) AVPR1AGPR119NR1H2MKNK1
SCHEMBL26066372 0.83 USP2 (0.39) AVPR1AUSP2SMN1; SMN2HDAC1HDAC8
SCHEMBL25360337 0.82 SIGMAR1 (0.48) AVPR1AUSP2SMN1; SMN2HDAC1HDAC8
SCHEMBL1808216 0.77 HDAC1 (0.39) AVPR1AUSP2SMN1; SMN2HDAC1HDAC8
SCHEMBL26046989 0.76 KCNH2 (0.41) GPR119KDM4EMAPTTHRB
SCHEMBL1805309 0.76 OPRL1 (0.48)
SCHEMBL12701504 0.75 AVPR1A (0.55) AVPR1AUSP2SMN1; SMN2HDAC1HDAC8
SCHEMBL26046988 0.75 AVPR1A (0.33) AVPR1ANR1H2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed